7-105567208-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_021930.6(RINT1):​c.2276C>T​(p.Pro759Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00748 in 1,613,198 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P759S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0052 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0077 ( 56 hom. )

Consequence

RINT1
NM_021930.6 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.69

Publications

7 publications found
Variant links:
Genes affected
RINT1 (HGNC:21876): (RAD50 interactor 1) This gene encodes a protein first identified for its ability to interact with the RAD50 double strand break repair protein, with the resulting interaction implicated in the regulation of cell cycle progression and telomere length. The encoded protein may also play a role in trafficking of cellular cargo from the endosome to the trans-Golgi network. Mutations in this gene may be associated with breast cancer in human patients. [provided by RefSeq, Oct 2016]
EFCAB10 (HGNC:34531): (EF-hand calcium binding domain 10) Predicted to enable calcium ion binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006407976).
BP6
Variant 7-105567208-C-T is Benign according to our data. Variant chr7-105567208-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 224921.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00524 (798/152330) while in subpopulation NFE AF = 0.00848 (577/68034). AF 95% confidence interval is 0.00791. There are 3 homozygotes in GnomAd4. There are 352 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RINT1NM_021930.6 linkc.2276C>T p.Pro759Leu missense_variant Exon 15 of 15 ENST00000257700.7 NP_068749.3 Q6NUQ1
EFCAB10NM_001355526.2 linkc.383+259G>A intron_variant Intron 4 of 4 ENST00000480514.6 NP_001342455.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RINT1ENST00000257700.7 linkc.2276C>T p.Pro759Leu missense_variant Exon 15 of 15 1 NM_021930.6 ENSP00000257700.2 Q6NUQ1
EFCAB10ENST00000480514.6 linkc.383+259G>A intron_variant Intron 4 of 4 1 NM_001355526.2 ENSP00000418678.1 A6NFE3

Frequencies

GnomAD3 genomes
AF:
0.00525
AC:
799
AN:
152212
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.00179
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00848
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00545
AC:
1366
AN:
250478
AF XY:
0.00539
show subpopulations
Gnomad AFR exome
AF:
0.00129
Gnomad AMR exome
AF:
0.00207
Gnomad ASJ exome
AF:
0.0148
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00273
Gnomad NFE exome
AF:
0.00786
Gnomad OTH exome
AF:
0.00671
GnomAD4 exome
AF:
0.00772
AC:
11276
AN:
1460868
Hom.:
56
Cov.:
30
AF XY:
0.00762
AC XY:
5540
AN XY:
726698
show subpopulations
African (AFR)
AF:
0.00164
AC:
55
AN:
33450
American (AMR)
AF:
0.00209
AC:
93
AN:
44466
Ashkenazi Jewish (ASJ)
AF:
0.0181
AC:
472
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39674
South Asian (SAS)
AF:
0.00463
AC:
398
AN:
85926
European-Finnish (FIN)
AF:
0.00275
AC:
147
AN:
53406
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5762
European-Non Finnish (NFE)
AF:
0.00863
AC:
9594
AN:
1111690
Other (OTH)
AF:
0.00845
AC:
510
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
569
1138
1708
2277
2846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
364
728
1092
1456
1820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00524
AC:
798
AN:
152330
Hom.:
3
Cov.:
32
AF XY:
0.00472
AC XY:
352
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00156
AC:
65
AN:
41582
American (AMR)
AF:
0.00307
AC:
47
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00455
AC:
22
AN:
4830
European-Finnish (FIN)
AF:
0.00179
AC:
19
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00848
AC:
577
AN:
68034
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
37
74
112
149
186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00788
Hom.:
7
Bravo
AF:
0.00482
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.0104
AC:
40
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.00942
AC:
81
ExAC
AF:
0.00546
AC:
663
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00736
EpiControl
AF:
0.00705

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 02, 2020
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

-
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

The RINT1 p.Pro418Leu variant was not identified in the literature nor was it identified in Cosmic. The variant was identified in dbSNP (ID: rs34310648), ClinVar (classified as benign by Invitae), and LOVD 3.0. The variant was identified in control databases in 1493 of 267350 chromosomes (4 homozygous) at a frequency of 0.005584 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1, non-cancer). The variant was observed in the following populations: Ashkenazi Jewish in 149 of 9852 chromosomes (freq: 0.01512), European (non-Finnish) in 995 of 117934 chromosomes (freq: 0.008437), Other in 50 of 6678 chromosomes (freq: 0.007487), South Asian in 133 of 30174 chromosomes (freq: 0.004408), European (Finnish) in 64 of 25096 chromosomes (freq: 0.00255), Latino in 69 of 34774 chromosomes (freq: 0.001984) and African in 33 of 23618 chromosomes (freq: 0.001397), but was not observed in the East Asian population. The p.Pro418 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. -

not provided Benign:2
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

EFCAB10: BS2; RINT1: BP4, BS2 -

RINT1-related disorder Benign:1
Apr 01, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.47
N
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.0092
T
MetaRNN
Benign
0.0064
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
L
PhyloP100
2.7
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.052
Sift
Benign
0.030
D
Sift4G
Uncertain
0.032
D
Polyphen
0.015
B
Vest4
0.20
MVP
0.43
MPC
0.20
ClinPred
0.016
T
GERP RS
5.1
Varity_R
0.098
gMVP
0.30
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34310648; hg19: chr7-105207655; COSMIC: COSV99072178; COSMIC: COSV99072178; API